Novel Treatment Criteria for Persistent Ductus Arteriosus in Neonates

• Main Authors: Hiroyuki Nagasawa, Daisuke Terazawa, Yoshinori Kohno, Yutaka Yamamoto, Masashi Kondo, Masami Sugawara, Toshinari Koyama, Ryosuke Miura
• Format: Article
• Language: English
• Published: Elsevier 2014-08-01
• Series: Pediatrics and Neonatology
• Subjects: left ventricular end-diastolic dimension; Qp/Qs; treatment criteria; two-dimensional echocardiography; very-low-birth-weight infant
• Online Access: http://www.sciencedirect.com/science/article/pii/S1875957213002246

The indications for ductus arteriosus ligation in very-low-birth-weight infants (VLBWIs) with persistent ductus arteriosus (PDA) are unclear. Increased left ventricular end-diastolic dimension (LVDd) is commonly found in patients with PDA. Here, the enlargement of LVDd in term and preterm neonates without congenital heart disease was estimated by two-dimensional echocardiography. Methods: The value of the measured LVDd was divided by the normal LVDd as an index (LVDd ratio) to compare 30 patients who underwent PDA ligation with 30 patients treated with indomethacin and 30 patients who did not undergo radical therapy. Results: An LVDd ratio between 122% and 197% (mean, 142%) was considered to be an indication for the ligation procedure. The proportion of patients exceeding 130% in the LVDd ratio was 87% (26/30) in those patients who underwent ligation. Catecholamines and/or vasodilators were required in 83% patients for the treatment of low ejection fraction or hypertension after operations, suggesting that patients had been in preload and/or afterload remodeling failure during the operation. The percentage of patients with less than 115% in the LVDd ratio was 90% in the non-radical-therapy patients. The LVDd ratios of 130% and 115% were regarded as cut-off values for surgical ligation and indomethacin treatment. Conclusion: The LVDd ratio is a useful measure to determine the treatment of VLBWIs with PDA.